Eric Lefofsky and CancerLinQ – Beating Cancer Together

Eric Lefofsky is a leading name in the technological world but it might be surprising to hear his name in the medical field, but it’s becoming much more prominent. Mr. Lefofsky has teamed up with CancerLinQ to help bring big data to cancer treatment.

This tech genius propelled his name into the spotlight as the co-founder of Groupon as well as several other companies. His current company, Tempus, specializes in health tech to modernize cancer treatment. Mr. Lefofsky has used his skills and his wealth to help build a large database that will analyze patterns in cancer cases. Tempus has also teamed up with Precision Health AI to build the largest cancer care data library in the world

Mr. Lefofsky isn’t a new face to the medical world. He and his wife, Liz, have created and run the Lefofsky Family Foundation, and also donate large amounts of their personal funds to cancer charities. They have pledged to donate at least half their wealth to philanthropic endeavors over their lifetimes.

With such forward and progressive thinking, Eric is using his skills and technology to help propel cancer research and care forward. In his blog, Eric points out that with the advances being made to map the human genome, medicine can become a much more personalized field. Understanding the genome will allow doctors to build specified and individualized treatment for each patient. With these customized treatments, there will be less side effects and a higher survival rate.

The use of technology in medicine is not a new concept, but it will continue to move the field forward. It takes innovative thinkers combining new as well as proven technology with the passion and drive of the medical community to bring about these changes.

If the combination of Eric Lefkofsky, Tempus and CancerLinQ are an indication to the future of cancer care, we are on the right track.

About Eric: Facebook.com/eplefkofsky/

Leave a Reply

Your email address will not be published. Required fields are marked *